'The chicken or the egg?' Dilemma strikes back for the controlling mechanism in chordoma

Journal of Pathology

Volumn 228, Issue 3, 2012, Pages 261-265

  Szuhai, Karoly ^a   Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

bone neoplasm; bone tumour; brachyury; chordoma; gene network

Indexed keywords

CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRACHYURY; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CANCER CONTROL; CANCER GRADING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHORDOMA; GENE IDENTIFICATION; GENE MAPPING; GENE REGULATORY NETWORK; GENE TARGETING; HISTOPATHOLOGY; HUMAN; NONHUMAN; NOTOCHORD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE;

ANIMALS; BONE NEOPLASMS; CHORDOMA; FETAL PROTEINS; GENOMICS; HUMANS; T-BOX DOMAIN PROTEINS;

EID: 84867569116     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4102     Document Type: Review

References (31)

1. Müller H,. Ueber das Vorkommen von Resten der Chorda dorsalis bei Menschen nach der Geburt und über ihr Verhältniss zu den Gallertgeschwülsten am Clivus. Z Rationelle Med 1858; 2: 202-229.
2. Romeo S, Hogendoorn PC,. Brachyury and chordoma: the chondroid-chordoid dilemma resolved? J Pathol 2006; 209: 143-146.
3. McMaster ML, Goldstein AM, Bromley CM, et al,. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 2001; 12: 1-11.
4. Vujovic S, Henderson S, Presneau N, et al,. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 2006; 209: 157-165.
5. Dobrovolskaia-Zavadskaia N,. Sur la mortification spontanée de la queue chez la souris nouveau-née et sur l'existence d'un caractère (facteur) héréditaire 'non viable'. C R Seances Soc Biol 1927; 97: 114-116.
6. Herrmann BG, Labeit S, Poustka A, et al,. Cloning of the T gene required in mesoderm formation in the mouse. Nature 1990; 343: 617-622.
7. Wilkinson DG, Bhatt S, Herrmann BG,. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature 1990; 343: 657-659.
8. Kispert A, Ortner H, Cooke J, et al,. The chick Brachyury gene: developmental expression pattern and response to axial induction by localized activin. Dev Biol 1995; 168: 406-415.
9. Nelson AC, Pillay N, Henderson S, et al,. An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma. J Pathol 2012; 228: 274-283.
10. Hazelbag HM, Mooi WJ, Fleuren GJ, et al,. Chain-specific keratin profile of epithelioid soft-tissue sarcomas: an immunohistochemical study on synovial and epithelioid sarcoma. Appl Immunohistochem 1996; 4: 176-183.
11. Oakley GJ, Fuhrer K, Seethala RR,. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol 2008; 21: 1461-1469.
12. Szuhai K, Cleton-Jansen AM, Hogendoorn PC, et al,. Molecular pathology and its diagnostic use in bone tumors. Cancer Genet 2012; 205: 193-204.
13. Amary MF, Bacsi K, Maggiani F, et al,. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 2011; 224: 334-343.
14. Tirabosco R, Mangham DC, Rosenberg AE, et al,. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol 2008; 32: 572-580.
15. Mukherjee D, Chaichana KL, Gokaslan ZL, et al,. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. J Neurosurg Spine 2011; 14: 143-150.
16. Jambhekar NA, Rekhi B, Thorat K, et al,. Revisiting chordoma with brachyury, a 'new age' marker: analysis of a validation study on 51 cases. Arch Pathol Lab Med 2010; 134: 1181-1187.
17. Kikuchi Y, Yamaguchi T, Kishi H, et al,. Pulmonary tumor with notochordal differentiation: report of 2 cases suggestive of benign notochordal cell tumor of extraosseous origin. Am J Surg Pathol 2011; 35: 1158-1164.
18. Yang XR, Ng D, Alcorta DA, et al,. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nature Genet 2009; 41: 1176-1178.
19. Shalaby AA, Presneau N, Idowu BD, et al,. Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas. Mod Pathol 2009; 22: 996-1005.
20. Presneau N, Shalaby A, Ye H, et al,. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol 2011; 223: 327-335.
21. Hallor KH, Staaf J, Jonsson G, et al,. Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer 2008; 98: 434-442.
22. Le LP, Nielsen GP, Rosenberg AE, et al,. Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS One 2011; 6: e18846.
23. Naka T, Boltze C, Kuester D, et al,. Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression. Cancer 2005; 104: 1255-1263.
24. Mohseny AB, Szuhai K, Romeo S, et al,. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 2009; 219: 294-305.
25. Mohseny AB, Tieken C, van der Velden PA, et al,. Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma. Genes Chromosomes Cancer 2010; 49: 1095-1103.
26. Dijkman R, Tensen CP, Jordanova ES, et al,. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol 2006; 24: 296-305.
27. Huang HY, Illei PB, Zhao Z, et al,. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol 2005; 23: 548-558.
28. Stephens PJ, Greenman CD, Fu B, et al,. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011; 144: 27-40.
29. Shalaby A, Presneau N, Ye H, et al,. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol 2011; 223: 336-346.
30. Pillay N, Amary FM, Berisha F, et al,. P63 does not regulate brachyury expression in human chordomas and osteosarcomas. Histopathology 2011; 59: 1025-1027.
31. Walcott BP, Nahed BV, Mohyeldin A, et al,. Chordoma: current concepts, management, and future directions. Lancet Oncol 2012; 13: e69-e76.